Drugs / SCT520FF
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06672536 | Nov 2024 → Sep 2026 expected | wet macular degeneration | Sinocelltech Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SCT520FF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06672536 ↗ |
| Route | Intravitreal | “SCT520FF dose level 1，IVI” NCT06672536 ↗ |